| New advances in cervical cancer: from bench to bedside O D’Oria, G Corrado, AS Laganà, V Chiantera, E Vizza, A Giannini International journal of environmental research and public health 19 (12), 7094, 2022 | 60 | 2022 |
| Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization A Giannini, V Di Donato, F Sopracordevole, A Ciavattini, A Ghelardi, ... Vaccines 11 (3), 698, 2023 | 49 | 2023 |
| Role of genomic and molecular biology in the modulation of the treatment of endometrial cancer: narrative review and perspectives I Cuccu, O D’Oria, L Sgamba, E De Angelis, T Golia D’Augè, C Turetta, ... Healthcare 11 (4), 571, 2023 | 49 | 2023 |
| Prevention, screening, treatment and follow-up of gynecological cancers: state of art and future perspectives TG D'Augè, A Giannini, G Bogani, C Di Dio, AS Laganà, V Di Donato, ... Clinical and Experimental Obstetrics & Gynecology 50 (8), 160, 2023 | 47 | 2023 |
| Advances on prevention and screening of gynecologic tumors: are we stepping forward? A Giannini, G Bogani, E Vizza, V Chiantera, AS Laganà, L Muzii, ... Healthcare 10 (9), 1605, 2022 | 46 | 2022 |
| Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part II: evaluation of tolerability and safety V Di Donato, MC Schiavi, V Iacobelli, O D’oria, E Kontopantelis, ... Maturitas 121, 93-100, 2019 | 46 | 2019 |
| Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer V Di Donato, A Di Pinto, A Giannini, G Caruso, O D'Oria, F Tomao, ... Gynecologic oncology 161 (1), 4-10, 2021 | 45 | 2021 |
| Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part I: evaluation of efficacy V Di Donato, O D’oria, E Kontopantelis, T Simoncini, L Muzii, PB Panici Maturitas 121, 86-92, 2019 | 42 | 2019 |
| Radical hysterectomy for early stage cervical cancer G Bogani, V Di Donato, G Scambia, F Raspagliesi, V Chiantera, G Sozzi, ... International Journal of Environmental Research and Public Health 19 (18), 11641, 2022 | 41 | 2022 |
| Radiomics and molecular classification in endometrial cancer (The ROME Study): a step forward to a simplified precision medicine G Bogani, V Chiappa, S Lopez, C Salvatore, M Interlenghi, O D’Oria, ... Healthcare 10 (12), 2464, 2022 | 40 | 2022 |
| Age-adjusted Charlson comorbidity index predicts survival in endometrial cancer patients V Di Donato, O D’Oria, A Giannini, G Bogani, M Fischetti, G Santangelo, ... Gynecologic and Obstetric Investigation 87 (3-4), 191-199, 2022 | 40 | 2022 |
| Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers C Di Tucci, MC Schiavi, P Faiano, O D’Oria, G Prata, V Sciuga, A Giannini, ... Critical Reviews in Oncology/Hematology 128, 30-42, 2018 | 40 | 2018 |
| Preoperative frailty assessment in patients undergoing gynecologic oncology surgery: a systematic review V Di Donato, G Caruso, G Bogani, A Giannini, O D'Oria, G Perniola, ... Gynecologic Oncology 161 (1), 11-19, 2021 | 38 | 2021 |
| Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer G Bogani, V Di Donato, G Scambia, F Landoni, F Ghezzi, L Muzii, ... Gynecologic Oncology 166 (3), 561-566, 2022 | 37 | 2022 |
| The role of preoperative frailty assessment in patients affected by gynecological cancer. a narrative review O D'Oria, TG D'Auge, E Baiocco, C Vincenzoni, E Mancini, V Bruno, ... ITALIAN JOURNAL OF GYNAECOLOGY & OBSTETRICS 34 (2), 76-83, 2022 | 35 | 2022 |
| Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality? MC Schiavi, V Sciuga, A Giannini, F Vena, O D’oria, G Prata, C Di Tucci, ... Gynecological Endocrinology 34 (8), 666-669, 2018 | 35 | 2018 |
| Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome: outcome after 6 months of treatment with ospemifene MC Schiavi, A Di Pinto, V Sciuga, P Faiano, C Di Tucci, O D’oria, ... Gynecological Endocrinology 34 (2), 140-143, 2018 | 32 | 2018 |
| Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks: improvement in overactive bladder symptoms MC Schiavi, MA Zullo, P Faiano, O D’Oria, G Prata, V Colagiovanni, ... Gynecological Endocrinology 33 (12), 942-945, 2017 | 31 | 2017 |
| PARP inhibitors in newly diagnosed and recurrent ovarian cancer A Giannini, C Di Dio, V Di Donato, O D’oria, MG Salerno, G Capalbo, ... American Journal of Clinical Oncology 46 (9), 414-419, 2023 | 30 | 2023 |
| Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study V Di Donato, O D’Oria, M Scudo, G Prata, M Fischetti, F Lecce, ... Maturitas 135, 34-39, 2020 | 30 | 2020 |
